PMC:7205724 / 16049-16450 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"554","span":{"begin":49,"end":53},"obj":"Gene"},{"id":"555","span":{"begin":274,"end":278},"obj":"Gene"},{"id":"556","span":{"begin":373,"end":377},"obj":"Gene"},{"id":"557","span":{"begin":382,"end":386},"obj":"Gene"},{"id":"558","span":{"begin":341,"end":342},"obj":"Gene"},{"id":"559","span":{"begin":225,"end":226},"obj":"Gene"},{"id":"560","span":{"begin":212,"end":213},"obj":"Gene"},{"id":"561","span":{"begin":164,"end":165},"obj":"Gene"},{"id":"562","span":{"begin":103,"end":104},"obj":"Gene"},{"id":"563","span":{"begin":43,"end":48},"obj":"Species"},{"id":"564","span":{"begin":96,"end":102},"obj":"Species"},{"id":"565","span":{"begin":218,"end":224},"obj":"Species"}],"attributes":[{"id":"A554","pred":"tao:has_database_id","subj":"554","obj":"Gene:59272"},{"id":"A555","pred":"tao:has_database_id","subj":"555","obj":"Gene:59272"},{"id":"A556","pred":"tao:has_database_id","subj":"556","obj":"Gene:3949"},{"id":"A557","pred":"tao:has_database_id","subj":"557","obj":"Gene:1803"},{"id":"A558","pred":"tao:has_database_id","subj":"558","obj":"Gene:43740568"},{"id":"A559","pred":"tao:has_database_id","subj":"559","obj":"Gene:43740568"},{"id":"A560","pred":"tao:has_database_id","subj":"560","obj":"Gene:43740568"},{"id":"A561","pred":"tao:has_database_id","subj":"561","obj":"Gene:43740568"},{"id":"A562","pred":"tao:has_database_id","subj":"562","obj":"Gene:43740568"},{"id":"A563","pred":"tao:has_database_id","subj":"563","obj":"Tax:9606"},{"id":"A564","pred":"tao:has_database_id","subj":"564","obj":"Tax:2697049"},{"id":"A565","pred":"tao:has_database_id","subj":"565","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Antiserum that contains antibodies against human ACE2 could hinder the entry of both SARS-S and SARS-2-S pseudotypes while not affected the entry of VSV-G and MERS-S pseudotypes. It supports the notion that SARS-S and SARS-2-S utilize the same primary entry receptor, i.e., ACE2, which is different from the primary receptors VSV-G and MERS-S engage for cell entry that is LDLR and DPP4, respectively."}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T126","span":{"begin":354,"end":358},"obj":"Body_part"}],"attributes":[{"id":"A126","pred":"fma_id","subj":"T126","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Antiserum that contains antibodies against human ACE2 could hinder the entry of both SARS-S and SARS-2-S pseudotypes while not affected the entry of VSV-G and MERS-S pseudotypes. It supports the notion that SARS-S and SARS-2-S utilize the same primary entry receptor, i.e., ACE2, which is different from the primary receptors VSV-G and MERS-S engage for cell entry that is LDLR and DPP4, respectively."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T107","span":{"begin":85,"end":89},"obj":"Disease"},{"id":"T108","span":{"begin":96,"end":100},"obj":"Disease"},{"id":"T109","span":{"begin":207,"end":211},"obj":"Disease"},{"id":"T110","span":{"begin":218,"end":222},"obj":"Disease"}],"attributes":[{"id":"A107","pred":"mondo_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A108","pred":"mondo_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A109","pred":"mondo_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A110","pred":"mondo_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Antiserum that contains antibodies against human ACE2 could hinder the entry of both SARS-S and SARS-2-S pseudotypes while not affected the entry of VSV-G and MERS-S pseudotypes. It supports the notion that SARS-S and SARS-2-S utilize the same primary entry receptor, i.e., ACE2, which is different from the primary receptors VSV-G and MERS-S engage for cell entry that is LDLR and DPP4, respectively."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T210","span":{"begin":43,"end":48},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T211","span":{"begin":354,"end":358},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Antiserum that contains antibodies against human ACE2 could hinder the entry of both SARS-S and SARS-2-S pseudotypes while not affected the entry of VSV-G and MERS-S pseudotypes. It supports the notion that SARS-S and SARS-2-S utilize the same primary entry receptor, i.e., ACE2, which is different from the primary receptors VSV-G and MERS-S engage for cell entry that is LDLR and DPP4, respectively."}

    LitCovid-sample-PD-IDO

    {"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T69","span":{"begin":354,"end":358},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"Antiserum that contains antibodies against human ACE2 could hinder the entry of both SARS-S and SARS-2-S pseudotypes while not affected the entry of VSV-G and MERS-S pseudotypes. It supports the notion that SARS-S and SARS-2-S utilize the same primary entry receptor, i.e., ACE2, which is different from the primary receptors VSV-G and MERS-S engage for cell entry that is LDLR and DPP4, respectively."}

    LitCovid-sample-PD-NCBITaxon

    {"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T139","span":{"begin":43,"end":48},"obj":"Species"},{"id":"T140","span":{"begin":85,"end":89},"obj":"Species"},{"id":"T141","span":{"begin":96,"end":102},"obj":"Species"},{"id":"T142","span":{"begin":159,"end":163},"obj":"Species"},{"id":"T143","span":{"begin":207,"end":211},"obj":"Species"},{"id":"T144","span":{"begin":218,"end":224},"obj":"Species"},{"id":"T145","span":{"begin":336,"end":340},"obj":"Species"}],"attributes":[{"id":"A139","pred":"ncbi_taxonomy_id","subj":"T139","obj":"NCBItxid:9606"},{"id":"A140","pred":"ncbi_taxonomy_id","subj":"T140","obj":"NCBItxid:694009"},{"id":"A141","pred":"ncbi_taxonomy_id","subj":"T141","obj":"NCBItxid:2697049"},{"id":"A142","pred":"ncbi_taxonomy_id","subj":"T142","obj":"NCBItxid:1335626"},{"id":"A143","pred":"ncbi_taxonomy_id","subj":"T143","obj":"NCBItxid:694009"},{"id":"A144","pred":"ncbi_taxonomy_id","subj":"T144","obj":"NCBItxid:2697049"},{"id":"A145","pred":"ncbi_taxonomy_id","subj":"T145","obj":"NCBItxid:1335626"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"Antiserum that contains antibodies against human ACE2 could hinder the entry of both SARS-S and SARS-2-S pseudotypes while not affected the entry of VSV-G and MERS-S pseudotypes. It supports the notion that SARS-S and SARS-2-S utilize the same primary entry receptor, i.e., ACE2, which is different from the primary receptors VSV-G and MERS-S engage for cell entry that is LDLR and DPP4, respectively."}

    LitCovid-sample-sentences

    {"project":"LitCovid-sample-sentences","denotations":[{"id":"T128","span":{"begin":0,"end":178},"obj":"Sentence"},{"id":"T129","span":{"begin":179,"end":401},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Antiserum that contains antibodies against human ACE2 could hinder the entry of both SARS-S and SARS-2-S pseudotypes while not affected the entry of VSV-G and MERS-S pseudotypes. It supports the notion that SARS-S and SARS-2-S utilize the same primary entry receptor, i.e., ACE2, which is different from the primary receptors VSV-G and MERS-S engage for cell entry that is LDLR and DPP4, respectively."}

    LitCovid-sample-Pubtator

    {"project":"LitCovid-sample-Pubtator","denotations":[{"id":"563","span":{"begin":43,"end":48},"obj":"Species"},{"id":"554","span":{"begin":49,"end":53},"obj":"Gene"},{"id":"564","span":{"begin":96,"end":102},"obj":"Species"},{"id":"562","span":{"begin":103,"end":104},"obj":"Gene"},{"id":"561","span":{"begin":164,"end":165},"obj":"Gene"},{"id":"560","span":{"begin":212,"end":213},"obj":"Gene"},{"id":"565","span":{"begin":218,"end":224},"obj":"Species"},{"id":"559","span":{"begin":225,"end":226},"obj":"Gene"},{"id":"555","span":{"begin":274,"end":278},"obj":"Gene"},{"id":"558","span":{"begin":341,"end":342},"obj":"Gene"},{"id":"556","span":{"begin":373,"end":377},"obj":"Gene"},{"id":"557","span":{"begin":382,"end":386},"obj":"Gene"}],"attributes":[{"id":"A557","pred":"pubann:denotes","subj":"557","obj":"Gene:1803"},{"id":"A561","pred":"pubann:denotes","subj":"561","obj":"Gene:43740568"},{"id":"A563","pred":"pubann:denotes","subj":"563","obj":"Tax:9606"},{"id":"A556","pred":"pubann:denotes","subj":"556","obj":"Gene:3949"},{"id":"A554","pred":"pubann:denotes","subj":"554","obj":"Gene:59272"},{"id":"A562","pred":"pubann:denotes","subj":"562","obj":"Gene:43740568"},{"id":"A559","pred":"pubann:denotes","subj":"559","obj":"Gene:43740568"},{"id":"A564","pred":"pubann:denotes","subj":"564","obj":"Tax:2697049"},{"id":"A565","pred":"pubann:denotes","subj":"565","obj":"Tax:2697049"},{"id":"A555","pred":"pubann:denotes","subj":"555","obj":"Gene:59272"},{"id":"A558","pred":"pubann:denotes","subj":"558","obj":"Gene:43740568"},{"id":"A560","pred":"pubann:denotes","subj":"560","obj":"Gene:43740568"}],"text":"Antiserum that contains antibodies against human ACE2 could hinder the entry of both SARS-S and SARS-2-S pseudotypes while not affected the entry of VSV-G and MERS-S pseudotypes. It supports the notion that SARS-S and SARS-2-S utilize the same primary entry receptor, i.e., ACE2, which is different from the primary receptors VSV-G and MERS-S engage for cell entry that is LDLR and DPP4, respectively."}

    LitCovid-sample-Enju

    {"project":"LitCovid-sample-Enju","denotations":[{"id":"T85498","span":{"begin":0,"end":9},"obj":"NN"},{"id":"T54727","span":{"begin":10,"end":14},"obj":"WDT"},{"id":"T58025","span":{"begin":15,"end":23},"obj":"VBZ"},{"id":"T31794","span":{"begin":24,"end":34},"obj":"NNS"},{"id":"T72017","span":{"begin":35,"end":42},"obj":"IN"},{"id":"T23410","span":{"begin":43,"end":48},"obj":"JJ"},{"id":"T51011","span":{"begin":49,"end":53},"obj":"NN"},{"id":"T21969","span":{"begin":54,"end":59},"obj":"MD"},{"id":"T10956","span":{"begin":60,"end":66},"obj":"VB"},{"id":"T54161","span":{"begin":67,"end":70},"obj":"DT"},{"id":"T78002","span":{"begin":71,"end":76},"obj":"NN"},{"id":"T48418","span":{"begin":77,"end":79},"obj":"IN"},{"id":"T60794","span":{"begin":80,"end":84},"obj":"CC"},{"id":"T68393","span":{"begin":85,"end":91},"obj":"NN"},{"id":"T60207","span":{"begin":92,"end":95},"obj":"CC"},{"id":"T37089","span":{"begin":96,"end":104},"obj":"NN"},{"id":"T99631","span":{"begin":105,"end":116},"obj":"NNS"},{"id":"T70219","span":{"begin":117,"end":122},"obj":"IN"},{"id":"T16218","span":{"begin":123,"end":126},"obj":"RB"},{"id":"T76542","span":{"begin":127,"end":135},"obj":"VBN"},{"id":"T34278","span":{"begin":136,"end":139},"obj":"DT"},{"id":"T2430","span":{"begin":140,"end":145},"obj":"NN"},{"id":"T98023","span":{"begin":146,"end":148},"obj":"IN"},{"id":"T1819","span":{"begin":149,"end":154},"obj":"NN"},{"id":"T13278","span":{"begin":155,"end":158},"obj":"CC"},{"id":"T45315","span":{"begin":159,"end":165},"obj":"NN"},{"id":"T32075","span":{"begin":166,"end":177},"obj":"NNS"},{"id":"T4602","span":{"begin":179,"end":181},"obj":"PRP"},{"id":"T44962","span":{"begin":182,"end":190},"obj":"VBZ"},{"id":"T87111","span":{"begin":191,"end":194},"obj":"DT"},{"id":"T50457","span":{"begin":195,"end":201},"obj":"NN"},{"id":"T41218","span":{"begin":202,"end":206},"obj":"IN"},{"id":"T5721","span":{"begin":207,"end":213},"obj":"NN"},{"id":"T21671","span":{"begin":214,"end":217},"obj":"CC"},{"id":"T31105","span":{"begin":218,"end":226},"obj":"NN"},{"id":"T49586","span":{"begin":227,"end":234},"obj":"VBP"},{"id":"T31036","span":{"begin":235,"end":238},"obj":"DT"},{"id":"T80074","span":{"begin":239,"end":243},"obj":"JJ"},{"id":"T64684","span":{"begin":244,"end":251},"obj":"JJ"},{"id":"T36069","span":{"begin":252,"end":257},"obj":"NN"},{"id":"T27754","span":{"begin":258,"end":266},"obj":"NN"},{"id":"T79207","span":{"begin":266,"end":267},"obj":"-COMMA-"},{"id":"T14629","span":{"begin":268,"end":272},"obj":"FW"},{"id":"T9665","span":{"begin":272,"end":273},"obj":"-COMMA-"},{"id":"T94116","span":{"begin":274,"end":278},"obj":"NN"},{"id":"T13974","span":{"begin":278,"end":279},"obj":"-COMMA-"},{"id":"T82487","span":{"begin":280,"end":285},"obj":"WDT"},{"id":"T59931","span":{"begin":286,"end":288},"obj":"VBZ"},{"id":"T21885","span":{"begin":289,"end":298},"obj":"JJ"},{"id":"T2868","span":{"begin":299,"end":303},"obj":"IN"},{"id":"T75369","span":{"begin":304,"end":307},"obj":"DT"},{"id":"T44853","span":{"begin":308,"end":315},"obj":"JJ"},{"id":"T60868","span":{"begin":316,"end":325},"obj":"NNS"},{"id":"T62157","span":{"begin":326,"end":331},"obj":"NN"},{"id":"T53624","span":{"begin":332,"end":335},"obj":"CC"},{"id":"T83630","span":{"begin":336,"end":342},"obj":"NN"},{"id":"T67890","span":{"begin":343,"end":349},"obj":"NN"},{"id":"T48926","span":{"begin":350,"end":353},"obj":"IN"},{"id":"T62543","span":{"begin":354,"end":358},"obj":"NN"},{"id":"T63733","span":{"begin":359,"end":364},"obj":"NN"},{"id":"T54619","span":{"begin":365,"end":369},"obj":"WDT"},{"id":"T50860","span":{"begin":370,"end":372},"obj":"VBZ"},{"id":"T99869","span":{"begin":373,"end":377},"obj":"NN"},{"id":"T6180","span":{"begin":378,"end":381},"obj":"CC"},{"id":"T74051","span":{"begin":382,"end":386},"obj":"NN"},{"id":"T7846","span":{"begin":386,"end":387},"obj":"-COMMA-"},{"id":"T3162","span":{"begin":388,"end":400},"obj":"RB"}],"relations":[{"id":"R33669","pred":"arg1Of","subj":"T85498","obj":"T54727"},{"id":"R60809","pred":"arg1Of","subj":"T85498","obj":"T58025"},{"id":"R58480","pred":"arg2Of","subj":"T31794","obj":"T58025"},{"id":"R48104","pred":"arg1Of","subj":"T31794","obj":"T72017"},{"id":"R83525","pred":"arg2Of","subj":"T51011","obj":"T72017"},{"id":"R75777","pred":"arg1Of","subj":"T51011","obj":"T23410"},{"id":"R9363","pred":"arg1Of","subj":"T85498","obj":"T21969"},{"id":"R63232","pred":"arg2Of","subj":"T10956","obj":"T21969"},{"id":"R12975","pred":"arg1Of","subj":"T85498","obj":"T10956"},{"id":"R91188","pred":"arg2Of","subj":"T78002","obj":"T10956"},{"id":"R80403","pred":"arg1Of","subj":"T78002","obj":"T54161"},{"id":"R89421","pred":"arg1Of","subj":"T78002","obj":"T48418"},{"id":"R99899","pred":"arg2Of","subj":"T99631","obj":"T48418"},{"id":"R64065","pred":"arg1Of","subj":"T99631","obj":"T60794"},{"id":"R92749","pred":"arg1Of","subj":"T99631","obj":"T68393"},{"id":"R99421","pred":"arg1Of","subj":"T68393","obj":"T60207"},{"id":"R58905","pred":"arg2Of","subj":"T37089","obj":"T60207"},{"id":"R42628","pred":"arg1Of","subj":"T99631","obj":"T37089"},{"id":"R22357","pred":"arg1Of","subj":"T10956","obj":"T70219"},{"id":"R42281","pred":"arg2Of","subj":"T76542","obj":"T70219"},{"id":"R48533","pred":"arg1Of","subj":"T76542","obj":"T16218"},{"id":"R80889","pred":"arg2Of","subj":"T85498","obj":"T76542"},{"id":"R79405","pred":"arg3Of","subj":"T2430","obj":"T76542"},{"id":"R15400","pred":"arg1Of","subj":"T2430","obj":"T34278"},{"id":"R93157","pred":"arg1Of","subj":"T2430","obj":"T98023"},{"id":"R27618","pred":"arg2Of","subj":"T32075","obj":"T98023"},{"id":"R65884","pred":"arg1Of","subj":"T32075","obj":"T1819"},{"id":"R23798","pred":"arg1Of","subj":"T1819","obj":"T13278"},{"id":"R32091","pred":"arg2Of","subj":"T45315","obj":"T13278"},{"id":"R5011","pred":"arg1Of","subj":"T32075","obj":"T45315"},{"id":"R47396","pred":"arg1Of","subj":"T4602","obj":"T44962"},{"id":"R37669","pred":"arg2Of","subj":"T50457","obj":"T44962"},{"id":"R92599","pred":"arg1Of","subj":"T50457","obj":"T87111"},{"id":"R83550","pred":"arg2Of","subj":"T49586","obj":"T50457"},{"id":"R55546","pred":"arg1Of","subj":"T49586","obj":"T41218"},{"id":"R27782","pred":"arg1Of","subj":"T5721","obj":"T21671"},{"id":"R26981","pred":"arg2Of","subj":"T31105","obj":"T21671"},{"id":"R35338","pred":"arg1Of","subj":"T21671","obj":"T49586"},{"id":"R99271","pred":"arg2Of","subj":"T27754","obj":"T49586"},{"id":"R13635","pred":"arg1Of","subj":"T27754","obj":"T31036"},{"id":"R59126","pred":"arg1Of","subj":"T27754","obj":"T80074"},{"id":"R93750","pred":"arg1Of","subj":"T27754","obj":"T64684"},{"id":"R53724","pred":"arg1Of","subj":"T27754","obj":"T36069"},{"id":"R52768","pred":"arg1Of","subj":"T27754","obj":"T79207"},{"id":"R80345","pred":"arg1Of","subj":"T27754","obj":"T14629"},{"id":"R9702","pred":"arg1Of","subj":"T27754","obj":"T9665"},{"id":"R90018","pred":"arg2Of","subj":"T94116","obj":"T9665"},{"id":"R49876","pred":"arg1Of","subj":"T50457","obj":"T13974"},{"id":"R9222","pred":"arg1Of","subj":"T50457","obj":"T82487"},{"id":"R38725","pred":"arg1Of","subj":"T50457","obj":"T59931"},{"id":"R36526","pred":"arg2Of","subj":"T21885","obj":"T59931"},{"id":"R28408","pred":"arg1Of","subj":"T50457","obj":"T21885"},{"id":"R90719","pred":"arg1Of","subj":"T21885","obj":"T2868"},{"id":"R29591","pred":"arg2Of","subj":"T53624","obj":"T2868"},{"id":"R49023","pred":"arg1Of","subj":"T53624","obj":"T75369"},{"id":"R92127","pred":"arg1Of","subj":"T62157","obj":"T44853"},{"id":"R12822","pred":"arg1Of","subj":"T62157","obj":"T60868"},{"id":"R87251","pred":"arg1Of","subj":"T62157","obj":"T53624"},{"id":"R64835","pred":"arg2Of","subj":"T67890","obj":"T53624"},{"id":"R51417","pred":"arg1Of","subj":"T67890","obj":"T83630"},{"id":"R61217","pred":"arg1Of","subj":"T53624","obj":"T48926"},{"id":"R52514","pred":"arg2Of","subj":"T63733","obj":"T48926"},{"id":"R5834","pred":"arg1Of","subj":"T63733","obj":"T62543"},{"id":"R77219","pred":"arg1Of","subj":"T63733","obj":"T54619"},{"id":"R58389","pred":"arg1Of","subj":"T63733","obj":"T50860"},{"id":"R97853","pred":"arg2Of","subj":"T6180","obj":"T50860"},{"id":"R8551","pred":"arg1Of","subj":"T99869","obj":"T6180"},{"id":"R58115","pred":"arg2Of","subj":"T74051","obj":"T6180"},{"id":"R79160","pred":"arg1Of","subj":"T50860","obj":"T7846"},{"id":"R17700","pred":"arg1Of","subj":"T50860","obj":"T3162"}],"text":"Antiserum that contains antibodies against human ACE2 could hinder the entry of both SARS-S and SARS-2-S pseudotypes while not affected the entry of VSV-G and MERS-S pseudotypes. It supports the notion that SARS-S and SARS-2-S utilize the same primary entry receptor, i.e., ACE2, which is different from the primary receptors VSV-G and MERS-S engage for cell entry that is LDLR and DPP4, respectively."}

    LitCovid-sample-PD-FMA

    {"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T126","span":{"begin":354,"end":358},"obj":"Body_part"}],"attributes":[{"id":"A126","pred":"fma_id","subj":"T126","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Antiserum that contains antibodies against human ACE2 could hinder the entry of both SARS-S and SARS-2-S pseudotypes while not affected the entry of VSV-G and MERS-S pseudotypes. It supports the notion that SARS-S and SARS-2-S utilize the same primary entry receptor, i.e., ACE2, which is different from the primary receptors VSV-G and MERS-S engage for cell entry that is LDLR and DPP4, respectively."}

    LitCovid-sample-PD-MONDO

    {"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T103","span":{"begin":85,"end":89},"obj":"Disease"},{"id":"T104","span":{"begin":96,"end":100},"obj":"Disease"},{"id":"T105","span":{"begin":207,"end":211},"obj":"Disease"},{"id":"T106","span":{"begin":218,"end":222},"obj":"Disease"}],"attributes":[{"id":"A103","pred":"mondo_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A104","pred":"mondo_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A105","pred":"mondo_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A106","pred":"mondo_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Antiserum that contains antibodies against human ACE2 could hinder the entry of both SARS-S and SARS-2-S pseudotypes while not affected the entry of VSV-G and MERS-S pseudotypes. It supports the notion that SARS-S and SARS-2-S utilize the same primary entry receptor, i.e., ACE2, which is different from the primary receptors VSV-G and MERS-S engage for cell entry that is LDLR and DPP4, respectively."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T128","span":{"begin":0,"end":178},"obj":"Sentence"},{"id":"T129","span":{"begin":179,"end":401},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Antiserum that contains antibodies against human ACE2 could hinder the entry of both SARS-S and SARS-2-S pseudotypes while not affected the entry of VSV-G and MERS-S pseudotypes. It supports the notion that SARS-S and SARS-2-S utilize the same primary entry receptor, i.e., ACE2, which is different from the primary receptors VSV-G and MERS-S engage for cell entry that is LDLR and DPP4, respectively."}